Zimmer's iASSIST Knee not a threat to MAKO, says William Blair William Blair views Zimmer's (ZMH) iASSIST Knee, as a threat to MAKO Surgical's partial]knee business at present. The firm believes it will take several years for Zimmer to develop the clinical data necessary for surgeons to feel comfortable using the product. William Blair expects MAKO will begin to start meeting or exceeding consensus expectations and keeps an Outperform rating on the stock.
Zimmer Acquires bone void filler maker ETEX Holdings Zimmer Holdings announced that it has acquired the business of ETEX Holdings. The financial terms of the transaction were not disclosed. The acquisition enhances Zimmer's Biologics portfolio of treatments through the addition of ETEX's Beta-bsm, CarriGen, EquivaBone, and Gamma-bsm bone void filler products.